Policresulen
Star1
This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Generic Name
- Policresulen
- DrugBank Accession Number
- DB13492
- Background
Not Available
- Type
- Small Molecule
- Groups
- Experimental, Investigational
- Synonyms
- Policresulen
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Associated Conditions
Indication Type Indication Combined Product Details Approval Level Age Group Patient Characteristics Dose Form Adjunct therapy in treatment of Trichomonas vaginalis infection •••••••••••• ••• Adjunct therapy in treatment of Vaginal infections •••••••••••• ••• - Associated Therapies
- Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Products
- Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.
- Brand Name Prescription Products
Name Dosage Strength Route Labeller Marketing Start Marketing End Region Image Jujiafenhuangquan Yindaoshuan Suppository 90 mg/1U Vaginal Heilongjiang Tianlong Pharmaceutical Co Ltd 2024-03-01 Not applicable US Jujiafenhuangquan Yindaoshuan Suppository 1 U/90mg Vaginal Heilongjiang Tianlong Pharmaceutical Co Ltd 2024-03-01 Not applicable US PolicresulenVaginalSuppository Solution 1 mg/720g Buccal; Vaginal Heilongjiang Tianlong Pharmaceutical Co Ltd 2024-03-01 Not applicable US - Over the Counter Products
Name Dosage Strength Route Labeller Marketing Start Marketing End Region Image Albothyl Solution 720 mg/1mL Buccal OASIS TRADING 2018-11-21 Not applicable US Albothyl Liquid 720 mg/1g Oral Lydia Co., Ltd. 2023-01-23 Not applicable US ALBOTHYL VAGINAL SUPPOSITORIES Suppository 90 mg Vaginal Takeda Malaysia Sdn Bhd 2020-09-08 2022-01-14 Malaysia ALBOTHYL VAGINAL SUPPOSITORY 90 mg Suppository 90 mg Vaginal TAKEDA PHARMACEUTICALS (ASIA PACIFIC) PTE. LTD. 1989-06-30 Not applicable Singapore Jujiafenhuangquan Yindaoshuan Suppository 1 g/90mg Vaginal Heilongjiang Tianlong Pharmaceutical Co Ltd 2024-03-06 Not applicable US - Mixture Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image FAKTU SUPPOSITORY Policresulen (100 mg) + Cinchocaine hydrochloride (2.5 mg) Suppository Rectal TAKEDA PHARMACEUTICALS (ASIA PACIFIC) PTE. LTD. 1988-04-26 Not applicable Singapore - Unapproved/Other Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image Albothyl Policresulen (720 mg/1mL) Solution Buccal OASIS TRADING 2018-11-21 Not applicable US Albothyl Policresulen (720 mg/1g) Liquid Oral Lydia Co., Ltd. 2023-01-23 Not applicable US Jujiafenhuangquan Yindaoshuan Policresulen (1 U/90mg) Suppository Vaginal Heilongjiang Tianlong Pharmaceutical Co Ltd 2024-03-01 Not applicable US Jujiafenhuangquan Yindaoshuan Policresulen (1 g/90mg) Suppository Vaginal Heilongjiang Tianlong Pharmaceutical Co Ltd 2024-03-06 Not applicable US Jujiafenhuangquan Yindaoshuan Policresulen (90 mg/1U) Suppository Vaginal Heilongjiang Tianlong Pharmaceutical Co Ltd 2024-03-01 Not applicable US
Categories
- ATC Codes
- D08AE02 — Policresulen
- D08AE — Phenol and derivatives
- D08A — ANTISEPTICS AND DISINFECTANTS
- D08 — ANTISEPTICS AND DISINFECTANTS
- D — DERMATOLOGICALS
- Drug Categories
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- 6I19M5GB0G
- CAS number
- 101418-00-2
- InChI Key
- Not Available
- InChI
- Not Available
- IUPAC Name
- Not Available
- SMILES
- Not Available
References
- General References
- DailyMed: Albothyl (policresulen) oral solution [Link]
- External Links
- 54908
- Wikipedia
- Policresulen
Clinical Trials
- Clinical Trials
Phase Status Purpose Conditions Count Not Available Unknown Status Treatment Vulva Intraepithelial Nonneoplastic 1
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Gel Vaginal Liquid Oral 720 mg/1g Solution Buccal 720 mg/1mL Solution Topical Suppository Vaginal Suppository Vaginal 90 mg Ointment Suppository Rectal 2.5 mg Gel Vaginal 3.6 g Suppository Vaginal 1 g/90mg Suppository Vaginal 1 U/90mg Suppository Vaginal 90 mg/1U Solution Insert Vaginal 100 MG Solution, concentrate 40 % Solution Buccal; Vaginal 1 mg/720g - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
- Predicted Properties
- Not Available
- Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
- Not Available
- Chromatographic Properties
Collision Cross Sections (CCS)
Not Available
Drug created at June 23, 2017 20:43 / Updated at September 28, 2021 21:54